Join
Live feed
·
INSIDERFilingvia Quantisnow
Indaptus Therapeutics Inc. logo

New insider Mcmurdo Matthew Charles claimed ownership of 25,000 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
INDP· Indaptus Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDP (Indaptus Therapeutics Inc.) and more on Quantisnow.